Robert A. Volkmann

Person

Mystic, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
NMDA receptor modulators and uses thereof
- Patent number 11,807,650
- Issue date Nov 7, 2023
- Novartis AG
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thienopyrimidinone NMDA receptor modulators and uses thereof
- Patent number 11,648,253
- Issue date May 16, 2023
- Novartis AG
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptide conjugates of cytotoxins as therapeutics
- Patent number 11,634,508
- Issue date Apr 25, 2023
- Cybrexa 2, Inc.
- Daniel Richard Marshall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptide conjugates of microtubule-targeting agents as therapeutics
- Patent number 11,555,019
- Issue date Jan 17, 2023
- Cybrexa 3, Inc.
- Daniel Richard Marshall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Thienopyrimidinone NMDA receptor modulators and uses thereof
- Patent number 11,541,057
- Issue date Jan 3, 2023
- Cadent Therapeutics, Inc.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic NMDA receptor modulators and uses thereof
- Patent number 11,542,264
- Issue date Jan 3, 2023
- Cadent Therapeutics, Inc.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
NMDA receptor modulators and uses thereof
- Patent number 11,274,107
- Issue date Mar 15, 2022
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oxabicycloheptane prodrugs
- Patent number 11,236,102
- Issue date Feb 1, 2022
- Lixte Biotechnology, Inc.
- John S. Kovach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic NMDA receptor modulators and uses thereof
- Patent number 11,236,104
- Issue date Feb 1, 2022
- Cadent Therapeutics, Inc.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B
- Patent number 11,116,749
- Issue date Sep 14, 2021
- Cadent Therapeutics, Inc.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Thienopyrimidinone NMDA receptor modulators and uses thereof
- Patent number 10,973,825
- Issue date Apr 13, 2021
- Cadent Therapeutics, Inc.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds, compositions, and methods for treatment of diseases invo...
- Patent number 10,933,069
- Issue date Mar 2, 2021
- Cybrexa 1, Inc.
- Daniel Richard Marshall
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[C]pyrrole negative allos...
- Patent number 10,781,174
- Issue date Sep 22, 2020
- Cadent Therapeutics, Inc.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic NMDA receptor modulators and uses thereof
- Patent number 10,752,633
- Issue date Aug 25, 2020
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic NMDA receptor modulators and uses thereof
- Patent number 10,626,122
- Issue date Apr 21, 2020
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oxabicycloheptane prodrugs
- Patent number 10,618,908
- Issue date Apr 14, 2020
- Lixte Biotechnology, Inc.
- John S. Kovach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic NMDA receptor modulators and uses thereof
- Patent number 10,584,131
- Issue date Mar 10, 2020
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thienopyrimidinone NMDA receptor modulators and uses thereof
- Patent number 10,500,205
- Issue date Dec 10, 2019
- Cadent Therapeutics, Inc.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Octahydrocyclopenta[c]pyrrole allosteric inhibitors of SHP2
- Patent number 10,435,389
- Issue date Oct 8, 2019
- Krouzon Pharmaccuticals, Inc.
- Robert Volkmann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oxabicycloheptane prodrugs
- Patent number 10,364,252
- Issue date Jul 30, 2019
- Lixte Biotechnology, Inc.
- John S. Kovach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[c]pyrrole negative allos...
- Patent number 10,239,835
- Issue date Mar 26, 2019
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for treatment of pain
- Patent number 10,072,018
- Issue date Sep 11, 2018
- BIOPHARMA WORKS
- Robert Volkmann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B
- Patent number 10,052,306
- Issue date Aug 21, 2018
- Cadent Therapeutics, Inc.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Metformin derivatives
- Patent number 10,017,529
- Issue date Jul 10, 2018
- BioPharma Works LLC
- Anton F Fliri
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oxabicycloheptane prodrugs
- Patent number 9,988,394
- Issue date Jun 5, 2018
- Lixte Biotechnology Inc.
- John S. Kovach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N-arylmethyl sulfonamide negative modulators of NR2A
- Patent number 9,963,434
- Issue date May 8, 2018
- LUC THERAPEUTICS, INC.
- David R Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B
- Patent number 9,540,324
- Issue date Jan 10, 2017
- LUC THERAPEUTICS, INC.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for treatment of pain
- Patent number 9,487,531
- Issue date Nov 8, 2016
- BioPharma Works LLC
- Robert Volkmann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-amino-6-(2,4,5-substituted-phenyl)-pyridines
- Patent number 6,803,470
- Issue date Oct 12, 2004
- Pfizer Inc.
- John A. Lowe
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fluoro-substituted adamantane derivatives
- Patent number 6,057,364
- Issue date May 2, 2000
- Pfizer Inc.
- Vytautas John Jasys
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
NMDA RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20240294546
- Publication date Sep 5, 2024
- Novartis AG
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20240199617
- Publication date Jun 20, 2024
- Novartis AG
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PEPTIDE CONJUGATES OF MICROTUBULE-TARGETING AGENTS AS THERAPEUTICS
- Publication number 20240067616
- Publication date Feb 29, 2024
- Cybrexa 3, Inc.
- Daniel Richard Marshall
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PEPTIDE CONJUGATES OF CYTOTOXINS AS THERAPEUTICS
- Publication number 20240010755
- Publication date Jan 11, 2024
- Cybrexa 2, Inc.
- Daniel Richard Marshall
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL AMIDE INHIBITORS OF CD38
- Publication number 20230382901
- Publication date Nov 30, 2023
- NAPA THERAPEUTICS LTD.
- Robert A. VOLKMANN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20230023543
- Publication date Jan 26, 2023
- Cadent Therapeutics, Inc.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE MODULATORS OF NR2B
- Publication number 20230012073
- Publication date Jan 12, 2023
- Cadent Therapeutics, Inc.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-ALKYLARYL-5-OXYARYL-OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE ALLOS...
- Publication number 20220274925
- Publication date Sep 1, 2022
- CADENT THERAPEUTICS, INC.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OXABICYCLOHEPTANE PRODRUGS
- Publication number 20220235066
- Publication date Jul 28, 2022
- Lixte Biotechnology, Inc.
- John S. KOVACH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NMDA RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20220153755
- Publication date May 19, 2022
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THIENOPYRIMIDINONE NMDA RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20220047600
- Publication date Feb 17, 2022
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THIENOPYRIMIDINONE NMDA RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20220016117
- Publication date Jan 20, 2022
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20210403474
- Publication date Dec 30, 2021
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATMENT OF DISEASES INVO...
- Publication number 20210299137
- Publication date Sep 30, 2021
- Cybrexa 1, Inc.
- Daniel Richard Marshall
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20210107916
- Publication date Apr 15, 2021
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PEPTIDE CONJUGATES OF CYTOTOXINS AS THERAPEUTICS
- Publication number 20210009719
- Publication date Jan 14, 2021
- Cybrexa 2, Inc.
- Daniel Richard Marshall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PEPTIDE CONJUGATES OF MICROTUBULE-TARGETING AGENTS AS THERAPEUTICS
- Publication number 20210009536
- Publication date Jan 14, 2021
- Cybrexa 3, Inc.
- Daniel Richard Marshall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-ALKYLARYL-5-OXYARYL-OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE ALLOS...
- Publication number 20200369610
- Publication date Nov 26, 2020
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OXABICYCLOHEPTANE PRODRUGS
- Publication number 20200325151
- Publication date Oct 15, 2020
- Lixte Biotechnology, Inc.
- JOHN S. KOVACH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20200131190
- Publication date Apr 30, 2020
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NMDA RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20200087323
- Publication date Mar 19, 2020
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20200039987
- Publication date Feb 6, 2020
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OXABICYCLOHEPTANE PRODRUGS
- Publication number 20190359627
- Publication date Nov 28, 2019
- Lixte Biotechnology, Inc.
- JOHN S. KOVACH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HYDROXYNORKETAMINE PRODRUGS
- Publication number 20190256487
- Publication date Aug 22, 2019
- BioPharmaWorks, LLC
- Robert A. Volkmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATMENT OF DISEASES INVO...
- Publication number 20190209580
- Publication date Jul 11, 2019
- Cybrexa, Inc.
- Daniel Richard Marshall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-ALKYLARYL-5-OXYARYL-OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE ALLOS...
- Publication number 20190152912
- Publication date May 23, 2019
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Octahydrocyclopenta[c]pyrrole Allosteric Inhibitors of SHP2
- Publication number 20190077792
- Publication date Mar 14, 2019
- Krouzon Pharmaceuticals, Inc.
- Robert Volkmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR TREATMENT OF PAIN
- Publication number 20190002473
- Publication date Jan 3, 2019
- BioPharma Works LLC
- Robert Volkmann
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THIENOPYRIMIDINONE NMDA RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20180369245
- Publication date Dec 27, 2018
- Cadent Therapeutics, Inc.
- David R. ANDERSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THIENOPYRIMIDINONE NMDA RECEPTOR MODUCLATORS AND USES THEREOF
- Publication number 20180360837
- Publication date Dec 20, 2018
- David R. ANDERSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Robert A. Volkmann

Person

Patents Grantslast 30 patents

NMDA receptor modulators and uses thereof

Thienopyrimidinone NMDA receptor modulators and uses thereof

Peptide conjugates of cytotoxins as therapeutics

Peptide conjugates of microtubule-targeting agents as therapeutics

Thienopyrimidinone NMDA receptor modulators and uses thereof

Heteroaromatic NMDA receptor modulators and uses thereof

NMDA receptor modulators and uses thereof

Oxabicycloheptane prodrugs

Heteroaromatic NMDA receptor modulators and uses thereof

Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B

Thienopyrimidinone NMDA receptor modulators and uses thereof

Compounds, compositions, and methods for treatment of diseases invo...

N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[C]pyrrole negative allos...

Heteroaromatic NMDA receptor modulators and uses thereof

Heteroaromatic NMDA receptor modulators and uses thereof

Oxabicycloheptane prodrugs

Heteroaromatic NMDA receptor modulators and uses thereof

Thienopyrimidinone NMDA receptor modulators and uses thereof

Octahydrocyclopenta[c]pyrrole allosteric inhibitors of SHP2

Oxabicycloheptane prodrugs

N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[c]pyrrole negative allos...

Compounds for treatment of pain

Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B

Metformin derivatives

Oxabicycloheptane prodrugs

N-arylmethyl sulfonamide negative modulators of NR2A

Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B

Compounds for treatment of pain

2-amino-6-(2,4,5-substituted-phenyl)-pyridines

Fluoro-substituted adamantane derivatives

Patents Applicationslast 30 patents

NMDA RECEPTOR MODULATORS AND USES THEREOF

HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF

PEPTIDE CONJUGATES OF MICROTUBULE-TARGETING AGENTS AS THERAPEUTICS

PEPTIDE CONJUGATES OF CYTOTOXINS AS THERAPEUTICS

HETEROARYL AMIDE INHIBITORS OF CD38

HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF

SELECTIVE OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE MODULATORS OF NR2B

N-ALKYLARYL-5-OXYARYL-OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE ALLOS...

OXABICYCLOHEPTANE PRODRUGS

NMDA RECEPTOR MODULATORS AND USES THEREOF

THIENOPYRIMIDINONE NMDA RECEPTOR MODULATORS AND USES THEREOF

THIENOPYRIMIDINONE NMDA RECEPTOR MODULATORS AND USES THEREOF

HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF

COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATMENT OF DISEASES INVO...

HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF

PEPTIDE CONJUGATES OF CYTOTOXINS AS THERAPEUTICS

PEPTIDE CONJUGATES OF MICROTUBULE-TARGETING AGENTS AS THERAPEUTICS

N-ALKYLARYL-5-OXYARYL-OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE ALLOS...

OXABICYCLOHEPTANE PRODRUGS

HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF

NMDA RECEPTOR MODULATORS AND USES THEREOF

HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF

OXABICYCLOHEPTANE PRODRUGS

HYDROXYNORKETAMINE PRODRUGS

COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATMENT OF DISEASES INVO...

N-ALKYLARYL-5-OXYARYL-OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE ALLOS...

Octahydrocyclopenta[c]pyrrole Allosteric Inhibitors of SHP2

COMPOUNDS FOR TREATMENT OF PAIN

THIENOPYRIMIDINONE NMDA RECEPTOR MODULATORS AND USES THEREOF

THIENOPYRIMIDINONE NMDA RECEPTOR MODUCLATORS AND USES THEREOF